William Anderson Wittekind - Apr 11, 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
10%+ Owner
Signature
/s/ William Anderson Wittekind
Stock symbol
RENB
Transactions as of
Apr 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/6/2023, 06:29 PM
Previous filing
Feb 6, 2023
Next filing
Feb 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Other +97K +1.96% 5.06M Apr 11, 2022 Weird Science LLC F1, F2
holding RENB Common Stock 2.71M Apr 11, 2022 Direct F3
holding RENB Common Stock 1.5M Apr 11, 2022 GRATs F4
holding RENB Common Stock 9.46M Apr 11, 2022 Spouse F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement.
F2 The Reporting Person is a manager of Weird Science LLC.
F3 Includes 88,121 shares held by the Reporting Person and his spouse as joint tenants with a right of survivorship (JTWROS).
F4 Shares held by certain grantor retained annuity trusts (GRATs) of which the Reporting Person is the sole trustee.
F5 Excludes 88,121 shares held with the Reporting Person as JTWROS. Such shares are included in the Reporting Person's direct beneficial ownership as described in note 3 above.
F6 The Reporting Person disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuniary interest therein, and for any other purpose.